~~<i id='9A7D6861EF'><strike id='9A7D6861EF'><tt id='9A7D6861EF'><pre id='9A7D6861EF'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：Wikipedia 2025-09-28 15:12:32 Page View：35

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Being 'nonadherent' patient made me a more empathetic doctor
Next article： As demand for Covid shots wanes, Moderna seeks its next success

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

2:34AUkrainiansoldierobserveshissurroundingfromashelteronthefrontlineintheZaporizhzhiaregion,Ukraine

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Parkinson’s finding may lead to tests and, someday, treatments

CourtesyMarkSeligerNEWYORK— MichaelJ.FoxwassittinginhisUpperEastSideofficesurroundedbyEmmysandanOsca